我们的孩子,我们的未来.

William Summerskill¹

¹The Lancet, London NW1 7BY, UK.

Lancet (London, England)

|June 7, 2005

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Healthy cities initiative in China: Progress, challenges, and the way forward.

The Lancet regional health. Western Pacific·2022

Same author

Healthy cities: key to a healthy future in China.

Lancet (London, England)·2018

Same author

The Lancet-CAMS Health Summit 2017: a call for abstracts from China.

Lancet (London, England)·2017

Same author

China-a call for papers.

Lancet (London, England)·2016

Same author

In appreciation of the peer-review heroes from 2015.

Lancet (London, England)·2016

Same author

Faith-based delivery of science-based care.

Lancet (London, England)·2015

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

我们的孩子,我们的未来.

相关概念视频

Healthy cities initiative in China: Progress, challenges, and the way forward.

Healthy cities: key to a healthy future in China.

The Lancet-CAMS Health Summit 2017: a call for abstracts from China.

China-a call for papers.

In appreciation of the peer-review heroes from 2015.

Faith-based delivery of science-based care.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

我们的孩子,我们的未来.

相关概念视频

Healthy cities initiative in China: Progress, challenges, and the way forward.

Healthy cities: key to a healthy future in China.

The Lancet-CAMS Health Summit 2017: a call for abstracts from China.

China-a call for papers.

In appreciation of the peer-review heroes from 2015.

Faith-based delivery of science-based care.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.